Robert Davidson
Family Medicine · Pinckneyville, ILNPI 1790774826
Payments from drug & device makers
Across 175 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$527
- Novo Nordisk$524
- Lilly USA, LLC$417
- AbbVie$308
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$195
- Novartis$161
- plus $958 from 21 others
What the payments were for
- Food & beverage$3,089100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $527 |
| Novo Nordisk | 30 | $524 |
| Lilly USA, LLC | 23 | $417 |
| AbbVie | 20 | $308 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $195 |
| Novartis | 6 | $161 |
| Boehringer Ingelheim | 9 | $142 |
| Mylan Specialty L.p. | 8 | $120 |
| Dexcom, Inc. | 7 | $119 |
| Amgen | 1 | $95 |
| Xeris Pharmaceuticals, Inc. | 5 | $85 |
| Bayer | 4 | $75 |
| Pfizer | 4 | $65 |
| Sunovion Pharmaceuticals Inc. | 2 | $36 |
| GSK | 2 | $27 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Grifols USA, LLC | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Astellas Pharma US Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$105
How this compares
$3,089 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 625 | $200,200 |
| JardianceEmpagliflozin | 73 | $49,815 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 113 | $35,494 |
| XareltoRivaroxaban | 89 | $26,146 |
| FarxigaDapagliflozin Propanediol | 55 | $16,684 |
| RybelsusSemaglutide | 11 | $16,435 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $15,924 |
| LinzessLinaclotide | 28 | $15,749 |
| NamzaricMemantine Hcl/Donepezil Hcl | 50 | $14,943 |
| MyrbetriqMirabegron | 62 | $14,762 |
| OzempicSemaglutide | 12 | $12,398 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,681 |
| Potassium Chloride | 519 | $9,078 |
| JanuviaSitagliptin Phosphate | 21 | $7,324 |
| LantusInsulin Glargine,hum.Rec.Anlog | 61 | $6,401 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $65 | $200,200625 claims |
| GSKArexvy, Trelegy Ellipta, Breo Ellipta | $27 | $56,145147 claims |
| Boehringer IngelheimJardiance | $142 | $49,81573 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta | $527 | $34,662101 claims |
| AbbVieLinzess, Namzaric | $308 | $30,69278 claims |
| Novo NordiskRybelsus, Ozempic | $524 | $28,83223 claims |
| Johnson & JohnsonXarelto | $12 | $26,14689 claims |
| Astellas Pharma US IncMyrbetriq | $11 | $14,76262 claims |
| Lilly USA, LLCHumalog | $417 | $3,49822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Pinckneyville
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.